Furthermore, Hes1 can serve as an immune microenvironment-related prognostic marker: in prostate cancer, its high expression is associated with M2-type TAMs and enhances tumor proliferation and invasion (142); in TNBC, Hes1 expression levels are significantly correlated with immune cell infiltration and immunosuppressive status (143). This evidence concerns the gene HES1 and prostate carcinoma.